GlaxoSmithKline

Forbes reports that pharmaceutical giant GlaxoSmithKline announced a plan to beginning collaborating with other companies on research into drugs for diseases that don't get a lot of attention, malaria being a key example. It sounds like open innovation in action. Read the Forbes article here, but... Read more
2 comments Posted 21 Jan 2010 by Chris Grams Feed